October 2014

The company bets that forging stronger ties with patients will result in more appropriate utilization

Susan Worley

More studies can help health plans identify what works — and what doesn’t — in different models, says this Rand researcher

John Marcille

Prices can be hard to swallow in this fastest-growing segment of the pharmaceutical market, but these approaches might help

Richard Mark Kirkner

Anonymized patient-level longitudinal data better supports formulary policy and coverage decisions, the authors say

 

Departments
LEGISLATION & REGULATION
They want to make it impossible for insurers to change provider networks after the enrollment period
Richard Mark Kirkner
MEDICATION MANAGEMENT
PGX testing improves therapy oversight by predicting nonresponders
and identifying patients at risk for adverse drug responses
Thomas Reinke
THE FORMULARY FILES
Krishna Rutvij Patel, PharmD
ACO UPDATE
Savings generated by the CMS program are not impressive, but quality measures show improvement
Peter Wehrwein
MEDICAL DEVICE MONITOR
Katherine T. Adams
TOMORROW’S MEDICINE
Cologuard is no substitute for colonoscopy for high-risk patients, but if this new tool means more people get screened, it could save lives
Thomas Morrow, MD

Our most popular topics on Managedcaremag.com